Genzyme | Sanofi, Clinical Trials Manufacturing & Clinical Fill Finish Facilities
This preconstruction and construction project spanned three locations in two buildings on Genzyme’s Framingham campus. The Clinical Trial Manufacturing (CTM) space is designed to produce new drugs in a cGMP standardized facility, whereas the Clinical Fill Finish Facility (CF3) is intended to accommodate the final stages of drug production/release. The project scope largely consisted of gutting and reconstructing manufacturing spaces and collaborating with the owner groups and process engineer. Work was performed in and/or on media and buffer manufacturing spaces, a suite of Bioreactors, and cGMP clean utilities. DCBA finalized project controls; tracked progress; controlled scheduling; and supplied procurement support, cost tracking, cash flow forecasts, and client-vendor management. DCBA also provided equipment maintenance information and formal commissioning and validation for the project.